SUBSCRIBE
SUBSCRIBE
News   Drug Development

ARCA Discovery Inc. Gets Fast-Track Status for Heart Drug

November 24, 2009 | 
1 min read

Bookmark and Share

Reuters -- ARCA biopharma Inc said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending its shares up as much as 81 percent.

Clinical research Phase II
MORE ON THIS TOPIC
Pictured: Boehringer Ingelheim sign on a building/
Schizophrenia
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessman jump careful on cracked or broken graph. Job opportunity and career. concept of under pressure. risk, financial, and tax
Pipeline
New Safety Signals Force Keros to Fully Terminate Mid-Stage PAH Study
January 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: A sign on a J.P. Morgan building in Hong Kong/iStock, danielvfung
Pipeline
JPM25 Day One: Pfizer, BioNTech, Moderna and More Present Pipeline Updates
January 14, 2025
 · 
3 min read
 · 
Dan Samorodnitsky